Double-Blind, Randomized, Phase 2a Study to Evaluate the Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix Tetra(®) or Afluria Quad(®).
Groth N, Bruhwyler J, Piat E, Tourneur J, Moris P, Penlington M, Nicolas F, Le Vert A
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.